Adenosquamous Carcinoma of the Endometrium - 13 Studies Found
Completed |
: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer :
|
Active, not recruiting |
: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer :
|
Completed |
: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus :
|